Product

The Measles and Rubella Viruses Real-Time PCR Kit is an in vitro diagnostic assay for the qualitative detection and differentiation of measles virus and rubella virus nucleic acids in throat swab specimens. It combines the functions of a measles test kit and a rubella test kit in a single real-time PCR assay. The multiplex PCR assay is intended for patients with signs and symptoms of respiratory infection, or skin symptoms considered together with clinical and epidemiological risk factors.

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. The World Health Organization (WHO), on March 11, 2020, declared that COVID-19 could be a pandemic. Anyone can get sick with COVID-19 and become seriously ill or die at any age. Influenza (Flu) is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. There are three types of influenza viruses: A, B, and C. FluA and FluB are the most common viruses that rout

Respiratory Virus Panel (7) Real Time PCR Kit is intended for the in-vitro qualitative detection of Influenza A virus, Influenza B virus, Respiratory syncytial virus , Human rhinovirus , Respiratory adenovirus, Mycoplasma pneumoniae, Parainfluenza virus nucleic acid in human throat swab samples. 7-in-1 Multiplex PCR assay: Detection and differentiation of 7 viral respiratory pathogens at once, in one run, saving time and resources Reliable: All controls included (positive and negative

The BioPerfectus Allfastra Respiratory Bacteria Panel (7) Real Time PCR Kit is an in vitro diagnostic test, based on multiplexed real-time PCR technology, for the simultaneous qualitative detection and differentiation of nucleic acids from multiple bacterial respiratory organisms(including Haemophilus influenzae, Mycoplasma pneumoniae, Legionella pneumophila, Klebsiella pneumoniae, Streptococcus pneumoniae,Bordetella parapertussisand Bordetella pertussis) from the human nasopharyngeal swab, sp

COVID-19 Coronavirus Real Time PCR Kit is an In Vitro Diagnostic (IVD) reagent applying on fluorescent PCR technology and aiming at qualitatively detect Open Reading Frame gene region (ORF1a/b) and viral nucleocapsid region (N) of SARS-CoV-2 RNA from upper and lower respiratory tract specimens. Upper respiratory tract specimens include throat swab and nasopharyngeal swab. Lower respiratory tract specimens include sputum. The product is intended for use on populations suspected to have SARS-C

The Influenza A and B Viruses Real Time PCR Kit provides a multiplex PCR test for flu, enabling qualitative detection of Influenza A and Influenza B virus RNA in a single assay. It is designed for clinical specimens including throat swabs, nasal and pharyngeal secretions, and cell culture supernatant. This influenza test kit uses target-specific real-time PCR detection for Flu A and Flu B and includes an internal control to monitor the testing process. The combined format helps laboratories

The BioPerfectus Allfastra Respiratory Bacteria Panel (3) Real Time PCR Kit is an in vitro diagnostic test, based on real-time PCR technology, for the detection of DNA from Pseudomonas aeruginosa, Group A Streptococcus and Staphylococcus aureus. Specimens can be obtained from the human nasopharyngeal swab, sputum and bronchoalveolar lavage fluid. 3-in-1 Multiplex PCR assay detects 3 respiratory bacteria in one tube 96 tests in 46 minutes (on one instrument) Internal control ensures th

COVID-19 Coronavirus and Influenza A/B virus Real Time PCR Kit is an In Vitro Diagnostic (IVD) reagent replying on fluorescent PCR technology and aiming at qualitatively detection and differentiation of RNA from SARS-CoV-2, influenza A virus, and/or influenza B virus from upper and lower respiratory tract samples. Upper and lower respiratory tract samples include throat swab and sputum. Multiplex real-time PCR detect different target specific for SARS-CoV-2, Flu A and Flu B Internal cont

In recent years, outbreaks of novel influenza A virus subtypes have occurred from time to time. For example, the novel influenza A H1N1 virus detected in Mexico in 2009 resulted in a global influenza pandemic. Novel influenza A H1N1 virus (2009) contains gene segments from an avian virus, a swine influenza virus, and a human seasonal influenza virus, leading to significant antigenic changes and causing higher morbidity and mortality. The current laboratory detection methods include virus isola

Influenza is an acute respiratory infectious disease caused by influenza viruses, which is mainly transmitted through airborne droplets. Influenza viruses are divided into types A, B, and C based on the differences in the antigenicity of nucleoprotein. Influenza B virus is a single-stranded RNA virus in the family Orthomyxoviridae. It can be classified into Victoria and Yamagata lineages based on the differences in antigenicity and gene specificity, and is the pathogen of influenza B, which is